Mobile Health Platform for Cystic Fibrosis
(NUDGE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smartphone program called NUDGE, designed to help teens and young adults with Cystic Fibrosis (CF) increase their physical activity. NUDGE acts as a digital coach, assisting users in setting and tracking goals, monitoring progress, and adjusting plans as needed. Participants will either use this program or receive standard education on CF management. The trial seeks individuals aged 13 to 25 who have CF, are medically stable, and are not currently experiencing a CF flare-up.
As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance CF management for others.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this mobile health platform is safe for adolescents and young adults with Cystic Fibrosis?
Research has shown that mobile health platforms like NUDGE help manage long-term health conditions. These platforms assist users in setting and tracking goals and provide feedback on their progress. For cystic fibrosis, the NUDGE program monitors participants' progress and ensures their safety.
Although specific data on the safety of NUDGE for cystic fibrosis is not available, similar apps have been safely used for conditions like diabetes. This trial is labeled "Not Applicable" for phase, indicating no serious safety issues are expected with the NUDGE program, as it is a digital tool, not a medication or surgery.
Mobile health tools are generally considered safe because they primarily involve using a smartphone app to guide health activities. Participants are usually closely monitored, allowing for quick resolution of any problems.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Health Platform for Cystic Fibrosis because it introduces the NUDGE program, a unique approach focusing on digital health solutions. Unlike traditional treatments that rely heavily on medications and physical therapy, NUDGE leverages mobile technology to provide personalized education and support. This platform aims to enhance self-management for patients by offering tailored health guidance and tracking, potentially leading to better adherence to treatment plans and improved quality of life. By integrating digital tools into patient care, this method offers a modern, accessible way to support individuals with cystic fibrosis.
What evidence suggests that the NUDGE platform is effective for increasing physical activity in adolescents and young adults with Cystic Fibrosis?
Research has shown that mobile health platforms can help people with cystic fibrosis improve their health habits and outcomes. This trial will compare two approaches: the NUDGE platform and an education-based approach. Studies have found that digital tools like NUDGE, which assist in setting and tracking health goals, enhance self-care and patient-focused results. These tools effectively motivate physical activity and help reach health targets. Additionally, evidence suggests that mobile health (mHealth) interventions can lead to better health outcomes, such as improved control of conditions like blood pressure and cholesterol. While NUDGE is specifically designed for young people with cystic fibrosis, its method has shown promise in encouraging healthier lifestyles and better disease management.12678
Are You a Good Fit for This Trial?
This trial is for adolescents and young adults aged 13-25 with Cystic Fibrosis who are medically stable, can communicate in English, and aren't currently having a CF-related health crisis. It aims to help those already active stay that way or encourage less active individuals to increase their physical activity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Completion of baseline study measures and return of actigraphy monitors
Treatment
Participants receive the NUDGE intervention content for 6 months
Delayed Treatment
Control group receives NUDGE intervention after Month 3
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- NUDGE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nemours Children's Clinic
Lead Sponsor
Cystic Fibrosis Foundation
Collaborator